Status:
COMPLETED
Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET
Lead Sponsor:
Technische Universität Dresden
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to describe the regional and global FDG-kinetics in non-small-cell lung cancer (NSCLC) during percutaneous radiation therapy.
Eligibility Criteria
Inclusion
- Histologically confirmed NSCLC not curable by surgery
- Karnofsky \> 80%
- Tumor volume and localization allow curative radiotherapy
- Written consent
Exclusion
- Metastases
- Diabetes
- Pregnancy
- Psychiatric impairment
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00180154
Start Date
July 1 2005
Last Update
August 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nuclear Medicine
Dresden, Germany, 01307